Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study

Filippo Randelli, Roberto D'Anchise, Vincenza Ragone, Luca Serrao, Paolo Cabitza, Pietro Randelli

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

An RCT was conducted to ascertain whether, compared to control management, topical application of a novel fibrin sealant (Evicel, J&J) in patients undergoing primary TKA reduces peri-operative blood loss. Sixty-two patients were randomized to receive topical application of Evicel (N. = 31) or not (N. = 31). The mean total blood loss was 1.9. L(±. 0.7) in the control group and 1.8. L(±. 0.5) in the treatment group (P= 0.4). The transfusion rate was 32.3% in the control group and 25.8% in the treatment group (P= 0.5). The transfusion rate decreased linearly with increasing preoperative Hb levels in the treatment group (P= 0.005). The results of this study suggest that topical application of this novel fibrin sealant doesn't reduce perioperative blood loss and the need for allogeneic blood transfusion.

Original languageEnglish
Pages (from-to)1516-1520
Number of pages5
JournalJournal of Arthroplasty
Volume29
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Knee Replacement Arthroplasties
Fibrin Tissue Adhesive
Control Groups
Blood Transfusion
Therapeutics

Keywords

  • Blood loss
  • Fibrin sealants
  • Total knee arthroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. / Randelli, Filippo; D'Anchise, Roberto; Ragone, Vincenza; Serrao, Luca; Cabitza, Paolo; Randelli, Pietro.

In: Journal of Arthroplasty, Vol. 29, No. 8, 2014, p. 1516-1520.

Research output: Contribution to journalArticle

Randelli, Filippo ; D'Anchise, Roberto ; Ragone, Vincenza ; Serrao, Luca ; Cabitza, Paolo ; Randelli, Pietro. / Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. In: Journal of Arthroplasty. 2014 ; Vol. 29, No. 8. pp. 1516-1520.
@article{53d0ddb1b34d4ae8abf250887fc0989f,
title = "Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study",
abstract = "An RCT was conducted to ascertain whether, compared to control management, topical application of a novel fibrin sealant (Evicel, J&J) in patients undergoing primary TKA reduces peri-operative blood loss. Sixty-two patients were randomized to receive topical application of Evicel (N. = 31) or not (N. = 31). The mean total blood loss was 1.9. L(±. 0.7) in the control group and 1.8. L(±. 0.5) in the treatment group (P= 0.4). The transfusion rate was 32.3{\%} in the control group and 25.8{\%} in the treatment group (P= 0.5). The transfusion rate decreased linearly with increasing preoperative Hb levels in the treatment group (P= 0.005). The results of this study suggest that topical application of this novel fibrin sealant doesn't reduce perioperative blood loss and the need for allogeneic blood transfusion.",
keywords = "Blood loss, Fibrin sealants, Total knee arthroplasty",
author = "Filippo Randelli and Roberto D'Anchise and Vincenza Ragone and Luca Serrao and Paolo Cabitza and Pietro Randelli",
year = "2014",
doi = "10.1016/j.arth.2014.02.024",
language = "English",
volume = "29",
pages = "1516--1520",
journal = "Journal of Arthroplasty",
issn = "0883-5403",
publisher = "Churchill Livingstone",
number = "8",

}

TY - JOUR

T1 - Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study

AU - Randelli, Filippo

AU - D'Anchise, Roberto

AU - Ragone, Vincenza

AU - Serrao, Luca

AU - Cabitza, Paolo

AU - Randelli, Pietro

PY - 2014

Y1 - 2014

N2 - An RCT was conducted to ascertain whether, compared to control management, topical application of a novel fibrin sealant (Evicel, J&J) in patients undergoing primary TKA reduces peri-operative blood loss. Sixty-two patients were randomized to receive topical application of Evicel (N. = 31) or not (N. = 31). The mean total blood loss was 1.9. L(±. 0.7) in the control group and 1.8. L(±. 0.5) in the treatment group (P= 0.4). The transfusion rate was 32.3% in the control group and 25.8% in the treatment group (P= 0.5). The transfusion rate decreased linearly with increasing preoperative Hb levels in the treatment group (P= 0.005). The results of this study suggest that topical application of this novel fibrin sealant doesn't reduce perioperative blood loss and the need for allogeneic blood transfusion.

AB - An RCT was conducted to ascertain whether, compared to control management, topical application of a novel fibrin sealant (Evicel, J&J) in patients undergoing primary TKA reduces peri-operative blood loss. Sixty-two patients were randomized to receive topical application of Evicel (N. = 31) or not (N. = 31). The mean total blood loss was 1.9. L(±. 0.7) in the control group and 1.8. L(±. 0.5) in the treatment group (P= 0.4). The transfusion rate was 32.3% in the control group and 25.8% in the treatment group (P= 0.5). The transfusion rate decreased linearly with increasing preoperative Hb levels in the treatment group (P= 0.005). The results of this study suggest that topical application of this novel fibrin sealant doesn't reduce perioperative blood loss and the need for allogeneic blood transfusion.

KW - Blood loss

KW - Fibrin sealants

KW - Total knee arthroplasty

UR - http://www.scopus.com/inward/record.url?scp=84905124191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905124191&partnerID=8YFLogxK

U2 - 10.1016/j.arth.2014.02.024

DO - 10.1016/j.arth.2014.02.024

M3 - Article

VL - 29

SP - 1516

EP - 1520

JO - Journal of Arthroplasty

JF - Journal of Arthroplasty

SN - 0883-5403

IS - 8

ER -